|
" Sub-unit vaccines for Brucella "
Jenner, Dominic Charles
| Document Type
|
:
|
Latin Dissertation
|
| Record Number
|
:
|
807982
|
| Doc. No
|
:
|
TLets504266
|
| Main Entry
|
:
|
Jenner, Dominic Charles
|
| Title & Author
|
:
|
Sub-unit vaccines for Brucella\ Jenner, Dominic Charles
|
| College
|
:
|
Open University
|
| Date
|
:
|
2009
|
| student score
|
:
|
2009
|
| Degree
|
:
|
Thesis (Ph.D.)
|
| Abstract
|
:
|
<i>Brucella</i> species are the causative agents of brucellosis, which is regarded as the world's most prevalent zoonotic disease. Brucellosis is endemic to the Middle East, Mexico, Asia, South America and the Mediterranean and causes significant economic losses in livestock in these areas of the world, as well as being a reservoir for human brucellosis. Although there are live attenuated vaccines available for brucellosis, they have many drawbacks when used in animals, and are still infectious to humans. It is clear from this that there is a need for a new effective vaccine for brucellosis for both animal and human use. There are increasing instances of ATP-binding cassette (ABC) systems being identified as virulence factors or potential vaccine candidates. In this study inventories of all the ABC systems encoded by five sequenced <i>Brucella</i> strains were compiled. These inventories were compared and differences have been found that could aid in the identification of virulence factors of <i>Brucella</i>. This study also explores the potential of ATP-binding cassette transporters as sub-unit vaccines against <i>Brucella melitensis</i> 16M. Eight ABC transporter proteins (PotD, PotF, Cgt, CydD, LolE, FbpA, OppA and ZnuA) have been produced using recombinant protein technologies, and their protective efficacy was evaluated in a number of studies using the murine model of <i>B. melitensis</i> infection. Of the eight vaccine candidates selected two have shown potential as novel vaccines against brucellosis. PotD and PotF are putative polyamine binding proteins of <i>Brucella</i> and show protection against experimental challenge of approximately 1x10<sup>4</sup> CFU of <i>B. melitensis</i> 16M when expressed by DNA vaccines or used in a PotD/PotF combination vaccine. Through this work a duel adjuvant system (ISCOMs and CpG) has been identified as a more effective adjuvant for <i>Brucella</i> vaccines than others previously used.
|
| Added Entry
|
:
|
Open University
|
| |